why is retatrutide better than tirzepatide vs. Tirzepatide: The Next-Gen GLP-1 Showdown Retatrutide vs Tirzepatide: What the

A new study reports that of the 1 million new GLP-1 medication users identified between 2011 to 2023, there was a twofold increase in GLP-1 medication users who do not have type 2 diabetes

While the prescribing information for GLP-1 medications does not specifically list Crohn's disease as a contraindication, the Summary of Product Characteristics (SmPC) for these medicines does advise caution in patients with gastrointestinal disease and states they are not recommended in severe gastrointestinal disease

Ashwagandha and L-theanine go together like peanut butter and jelly

1 If confirmed, the finding could eventually allow physicians to optimize GLP-1 dosing strategies with cardiovascular outcomes in mind, distinct from weight management goals